Abstract
India is of great interest to the world of pharmaceuticals. The domestic market ($13b) is growing at almost 10% compound annual growth rate (CAGR). The exports of pharmaceuticals from India ($15b) is growing at 12% CAGR. All the well-known names in the global sphere are now present in the Indian pharma market, and many are having formulation manufacturing units here. It is widely believed that companies in India can soon become the biggest suppliers of generic drugs to the world. Apart from affordable cost, the emphasis is now shifting to Current Good Manufacturing Practices (cGMP)/Current Good Manufacturing/Clinical/Lab/etc Practices (cGXP). What should a pharma manufacturer know about the present status of issues in India which will reflect on the future performance of this country. Can India really be the pharmacy of the world? Only time will tell, but the conditions of the road will more or less be understood through this article.
Keywords
Get full access to this article
View all access options for this article.